francine blumental de abreu - PHL © Elysio - FUNDAÇÃO ANTÔNIO ...

240
Selamat SA, Galler JS, Joshi AD, et al. DNA methylation changes in atypical
adenomatous hyperplasia, adenocarcinoma in situ, and lung
adenocarcinoma. PLoS One 2011; 6:e21443.
Shelling AN, Ferguson LR. Genetic variation in human disease and a new
role for copy number variants. Mutat Res 2007; 622:33-41.
Shen F, Liu X, Geng JG, Guo SW. Increased immunoreactivity to
SLIT/ROBO1 in ovarian endometriomas: a likely constituent biomarker for
recurrence. Am J Pathol 2009; 175:479-88.
Shigekawa T, Ijichi N, Ikeda K, et al. FOXP1, an estrogen-inducible
transcription factor, modulates cell proliferation in breast cancer cells and 5year
recurrence-free survival of patients with tamoxifen-treated breast
cancer. Horm Cancer 2011; 2:286-97.
Shlien A, Tabori U, Marshall CR, et al. Excessive genomic DNA copy number
variation in the Li-Fraumeni cancer predisposition syndrome. Proc Natl Acad
Sci U S A 2008; 105:11264-9.
Shlien A, Malkin D. Copy number variations and cancer. Genome Med 2009;
1:62.
Shlien A, Malkin D. Copy number variations and cancer susceptibility. Curr
Opin Oncol 2010; 22:55-63.
Shulman LP. Hereditary breast and ovarian cancer (HBOC): clinical features
and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden
syndrome, and Li-Fraumeni syndrome. Obstet Gynecol Clin North Am
2010; 37:109-33.